|
| 37358553 | Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study. | | 2023 |
| 37775612 | Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy. | | 2023 |
| 36638183 | Nicotinamide riboside improves muscle mitochondrial biogenesis, satellite cell differentiation, and gut microbiota in a twin study. | Sci Adv | 2023 |
| 34411351 | Effects of PNPLA3 I148M on hepatic lipid and very-low-density lipoprotein metabolism in humans. | Journal of Internal Medicine | 2022 |
| 35521766 | Role of endogenous incretins in the regulation of postprandial lipoprotein metabolism. | European Journal of Endocrinology | 2022 |
| 36040803 | Postprandial metabolism of apolipoproteins B48, B100, C-III, and E in humans with APOC3 loss-of-function mutations. | JCI insight | 2022 |
| 35318466 | Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia. | Nature Reviews Cardiology | 2022 |
| 34676434 | Metabolism of Triglyceride-Rich Lipoproteins. | Handbook of Experimental Pharmacology | 2022 |
| 34817888 | Apolipoprotein C-III predicts cardiovascular events and mortality in individuals with type 1 diabetes and albuminuria. | J Intern Med | 2022 |
| 34472586 | Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society. | European Heart Journal | 2021 |
| 33964025 | Remnant cholesterol predicts progression of diabetic nephropathy and retinopathy in type 1 diabetes. | J Intern Med | 2021 |
| 33715205 | Relationship between de novo lipogenesis and serum sex hormone binding globulin in humans. | Clinical Endocrinology | 2021 |
| 33502078 | Effects of liraglutide on the metabolism of triglyceride-rich lipoproteins in type 2 diabetes. | Diabetes, Obesity and Metabolism | 2021 |
| 33249422 | High-resolution population-specific recombination rates and their effect on phasing and genotype imputation. | European Journal of Human Genetics | 2021 |
| 33356392 | Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes. | Arteriosclerosis, Thrombosis, and Vascular Biology | 2021 |
| 34548531 | Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes. | Scientific Reports | 2021 |
| 32665614 | Liver nucleotide biosynthesis is linked to protection from vascular complications in individuals with long-term type 1 diabetes. | Sci Rep | 2020 |
| 31846520 | Apolipoprotein B48 metabolism in chylomicrons and very low-density lipoproteins and its role in triglyceride transport in normo- and hypertriglyceridemic human subjects. | Journal of Internal Medicine | 2020 |
| 32312974 | Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance. | Nature Communications | 2020 |
| 31631432 | Interaction of chylomicron remnants and VLDLs during ultracentrifuge separation based on the Svedberg flotation rate - Authors' response. | Journal of Internal Medicine | 2020 |
| 32243036 | Uric acid predicts long-term cardiovascular risk in type 2 diabetes but does not mediate the benefits of fenofibrate: The FIELD study. | Diabetes, Obesity and Metabolism | 2020 |
| 32052833 | Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. | European Heart Journal | 2020 |
| 32386566 | Niacin Cures Systemic NAD Deficiency and Improves Muscle Performance in Adult-Onset Mitochondrial Myopathy. | | 2020 |
| 32337855 | The acute effect of metabolic cofactor supplementation: a potential therapeutic strategy against non-alcoholic fatty liver disease. | Mol Syst Biol | 2020 |
| 32154731 | Polygenic Hyperlipidemias and Coronary Artery Disease Risk. | Circ Genom Precis Med | 2020 |
| 32089006 | Triglyceride concentrations and non-high-density lipoprotein cholesterol goal attainment in the ODYSSEY phase 3 trials with alirocumab. | European Journal of Preventive Cardiology | 2020 |
| 31753785 | A higher glycemic response to oral glucose is associated with higher plasma apolipoprotein C3 independently of BMI in healthy twins. | Nutrition, Metabolism and Cardiovascular Diseases | 2020 |
| 32477261 | Causes and Consequences of Hypertriglyceridemia. | Frontiers in Endocrinology | 2020 |
| 31917184 | Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjects. | Journal of Clinical Lipidology | 2020 |
| 33462955 | The dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes. | Diabetes, Obesity and Metabolism | 2020 |
| 32640244 | Niacin Cures Systemic NAD Deficiency and Improves Muscle Performance in Adult-Onset Mitochondrial Myopathy. | | 2020 |
| 32849270 | The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans. | Frontiers in Endocrinology | 2020 |
| 33170809 | Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans. | JCI insight | 2020 |
| 30779243 | Investigation of human apoB48 metabolism using a new, integrated non-steady-state model of apoB48 and apoB100 kinetics. | Journal of Internal Medicine | 2019 |
| 30073766 | Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single-centre randomized controlled study. | Diabetes, Obesity and Metabolism | 2019 |
| 30589487 | Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome. | Obesity Reviews | 2019 |
| 30972934 | Role of apolipoprotein C-III overproduction in diabetic dyslipidaemia. | Diabetes, Obesity and Metabolism | 2019 |
| 31443567 | Dietary Fructose and the Metabolic Syndrome. | Nutrients | 2019 |
| 31164165 | The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initia | Cardiovascular Diabetology | 2019 |
| 31256696 | Coronary Artery Disease Risk and Lipidomic Profiles Are Similar in Hyperlipidemias With Family History and Population-Ascertained Hyperlipidemias. | J Am Heart Assoc | 2019 |
| 31111320 | Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD. | Current Atherosclerosis Reports | 2019 |
| 29456073 | An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans. | Cell Metab | 2018 |
| 30545366 | USF1 deficiency alleviates inflammation, enhances cholesterol efflux and prevents cholesterol accumulation in macrophages. | Lipids in Health and Disease | 2018 |
| 30059843 | Efficacy and safety of alirocumab in individuals with type 2 diabetes mellitus with or without mixed dyslipidaemia: Analysis of the ODYSSEY LONG TERM trial. | Atherosclerosis | 2018 |
| 30242179 | Characterization of different fat depots in NAFLD using inflammation-associated proteome, lipidome and metabolome. | Sci Rep | 2018 |
| 29764718 | Metabolic syndrome associates with left atrial dysfunction. | Nutrition, Metabolism and Cardiovascular Diseases | 2018 |
| 28254760 | Personal model-assisted identification of NAD<sup>+</sup> and glutathione metabolism as intervention target in NAFLD. | Mol Syst Biol | 2017 |
| 28393441 | Intestinal alkaline phosphatase at the crossroad of intestinal health and disease - a putative role in type 1 diabetes. | J Intern Med | 2017 |
| 28772107 | Family-specific aggregation of lipid GWAS variants confers the susceptibility to familial hypercholesterolemia in a large Austrian family. | Atherosclerosis | 2017 |
| 28428027 | Fructose intervention for 12 weeks does not impair glycemic control or incretin hormone responses during oral glucose or mixed meal tests in obese men. | Nutrition, Metabolism and Cardiovascular Diseases | 2017 |